Markets:

Overview

News

Currencies

International

Treasuries

Articles published by GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Chuck E. Cheese Prices a Full Family Spring Break Outing at $49.99 While Competitors Average Over $125

Today 8:00 EST

From Chuck E. Cheese

Via GlobeNewswire

Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales

Today 8:00 EST

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Tickers NAUT

Proscia Earns Top Performance Score in the US, Sweeping 2026 KLAS Digital Pathology Ratings

Today 8:00 EST

From Proscia

Via GlobeNewswire

GetYourGuide Appoints Rob Rekrutiak as Chief Product Officer

Today 8:00 EST

From GetYourGuide

Via GlobeNewswire

UroGen Announces Refinanced Term Loan Agreement with Pharmakon Advisors

Today 7:55 EST

From UroGen Pharma Ltd.

Via GlobeNewswire

Tickers URGN

Cognition Therapeutics Advancing Zervimesine (CT1812) for Dementia with Lewy Bodies (DLB) Psychosis

Today 7:30 EST

From Cognition Therapeutics, Inc.

Via GlobeNewswire

Tickers CGTX

Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Today 7:30 EST

From Dyne Therapeutics, Inc.

Via GlobeNewswire

Tickers DYN

Telkomsel Expands Capsyl Cloud Deployment with Synchronoss

Today 7:30 EST

From Synchronoss Technologies, Inc.

Via GlobeNewswire

Tickers SNCR

Palvella Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Today 7:30 EST

From Palvella Therapeutics Inc.

Via GlobeNewswire

Tickers PVLA

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Today 7:30 EST

From Xilio Therapeutics, Inc.

Via GlobeNewswire

Tickers XLO

TEGNA Inc. Reports Fourth Quarter and Full-Year 2025 Results

Today 7:30 EST

From TEGNA Inc.

Via GlobeNewswire

Tickers TGNA

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution

Today 7:27 EST

From Eton Pharmaceuticals

Via GlobeNewswire

Tickers ETON

Alterity Therapeutics Recognizes Multiple System Atrophy (MSA) Awareness Month in March and the Urgent Need for Disease-Modifying Treatments

Today 7:25 EST

From ALTERITY THERAPEUTICS LIMITED

Via GlobeNewswire

Tickers ASX ATHE

Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone

Today 7:20 EST

From Dyadic International, Inc.

Via GlobeNewswire

Tickers DYAI

Zefiro Founder and Former Chairman Reports Initial Success in New York Litigation

Today 7:08 EST

From Talal A. Debs, Founder and Concerned Shareholder of Zefiro Methane Corp.

Via GlobeNewswire

uniQure Announces 2025 Financial Results and Provides Recent Company Updates

Today 7:05 EST

From uniQure Inc.

Via GlobeNewswire

Tickers QURE

HBT Financial, Inc. Completes Merger with CNB Bank Shares, Inc.

Today 7:05 EST

From HBT Financial, Inc.

Via GlobeNewswire

Tickers HBT

Ocugen Announces Phase 3 liMeliGhT Enrollment Completion for OCU400, a Novel Modifier Gene Therapy for Broad Retinitis Pigmentosa

Today 7:02 EST

From Ocugen

Via GlobeNewswire

Tickers OCGN

Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2025 Financial Results

Today 7:00 EST

From Apogee Therapeutics

Via GlobeNewswire

Tickers APGE

NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer

Today 7:00 EST

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

Tickers NRXP

Intuitive Expands Investment and Footprint in Europe

Today 7:00 EST

From Intuitive Surgical, Inc.

Via GlobeNewswire

Tickers ISRG

Digital Realty Enters Bulgaria with Acquisition of Highly Connected Interconnection Hub in Sofia

Today 7:00 EST

From Digital Realty Trust, L.P.

Via GlobeNewswire

Tickers DLR

MapLight Therapeutics to Participate in Upcoming Investor Conferences

Today 7:00 EST

From MapLight Therapeutics, Inc.

Via GlobeNewswire

Tickers MPLT

Hain Celestial Completes Sale of North American Snacks Business

Today 7:00 EST

From The Hain Celestial Group, Inc.

Via GlobeNewswire

Tickers HAIN

Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors

Today 7:00 EST

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

Tickers APLS

Kaspi.kz 4Q & FY 2025 Financial Results

Today 7:00 EST

From JSC Kaspi.kz

Via GlobeNewswire

Tickers KSPI

Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

Today 7:00 EST

From Sionna Therapeutics, Inc.

Via GlobeNewswire

Tickers SION

SPARC AI Appoints Matt McCrann as U.S. CEO

Today 7:00 EST

From SPARC AI INC

Via GlobeNewswire

Tickers CSE:SPAI SPAIF

Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform

Today 7:00 EST

From Royalty Pharma plc

Via GlobeNewswire

Tickers RPRX

ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative

Today 7:00 EST

From ADMA Biologics, Inc.

Via GlobeNewswire

Tickers ADMA

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.